Trump Reschedules Cannabis, Fentanyl Becomes WMD

President Trump’s recent executive order is setting the stage for a major realignment of federal drug policy, creating a striking contrast in how two substances—marijuana and fentanyl—are treated. By directing the reclassification of marijuana from Schedule I to Schedule III, the administration aims to facilitate medical research and industry growth. Simultaneously, fentanyl is being elevated to a national security threat, with federal agencies planning for its potential use as a weapon of mass destruction. This dual approach highlights a deep and complex divide, setting up clashes between state and federal laws and leading to significant implications for public health, security, and the economy.

Story Snapshot

President Trump has ordered marijuana to be reclassified from Schedule I to Schedule III.
Fentanyl is being treated as a potential weapon of mass destruction in federal planning.
The reclassification of marijuana aims to facilitate medical research and industry growth.
Federal and state legal inconsistencies remain a major challenge.

Trump Orders Marijuana Rescheduling

In a significant policy shift, President Trump has issued an executive order directing the reclassification of marijuana from Schedule I to Schedule III under the Controlled Substances Act. This move is intended to recognize the medical use of cannabis and alleviate some of the burdens on research and industry. The decision comes after years of advocacy from lawmakers and medical professionals who argue for the benefits of medical marijuana.

This reclassification is expected to ease federal restrictions, allowing for more extensive medical research. It also presents potential economic benefits by reducing tax burdens and improving financial access for cannabis businesses. However, the change does not override state laws that still prohibit marijuana use, creating a complex legal landscape for states like Texas, where marijuana remains illegal.

🚨🇺🇸 BREAKING: TRUMP TO SIGN MARIJUANA RECLASSIFICATION ORDER AS SOON AS MONDAY, CANNABIS STOCKS EXPLODE

The market is pricing in a new era.

Trump is expected to sign an executive order as soon as Monday directing federal agencies to reclassify marijuana from Schedule I… pic.twitter.com/YTCzS3lcF4

— Mario Nawfal (@MarioNawfal) December 12, 2025

Fentanyl: A Rising Threat

While marijuana is moving towards medical acceptance, fentanyl has caught the attention of federal agencies as a potential weapon of mass destruction. This classification underscores the opioid’s lethal potency and the risk it poses in mass-casualty scenarios. Federal agencies are intensifying their efforts to prepare for potential chemical attacks involving fentanyl, which could be used by terrorists or state actors in confined spaces.

Departments like Homeland Security and Defense are focusing on scenarios that treat fentanyl as a chemical threat. This includes stockpiling antidotes like naloxone and developing specialized protocols for first responders. The dual approach to cannabis and fentanyl highlights a policy realignment where cannabis is regulated for medical use while fentanyl is securitized as a national threat.

Implications and Challenges

The reclassification of marijuana to Schedule III could pave the way for more comprehensive reforms, potentially leading to full descheduling in the future. It may also encourage federal and state legal harmonization, as federal recognition of medical use contrasts with state prohibitions. However, this could result in market consolidation, where larger firms dominate due to their ability to comply with federal standards.

In contrast, the WMD framing of fentanyl could lead to stricter penalties and expanded law enforcement powers. It encourages closer integration between public health and security sectors to identify and mitigate risks of deliberate misuse. Internationally, this framing may necessitate more stringent diplomatic efforts with countries like China and Mexico to control the flow of fentanyl and its precursors.

Watch the report: Trump signs executive order to reclassify marijuana as a Schedule III drug